Main

type

0 (not classified)

status

21 (imported old-v2, waiting for another import)

review version

0

cleanup version

0

pending deletion

0 (-)

created at

2025-12-01 22:13:34

updated at

2025-12-01 22:13:35

Address

url

https://www.abbvie.ch/de/science/publication-of-clinical-trials/epcoritamab-tepkinly.html

url length

89

url crc

20438

url crc32

150294486

location type

1 (url matches target location, page_location is empty)

canonical status

10 (verified canonical url)

canonical page id

3064034925

Source

domain id

2495993

domain tld

756

domain parts

0

originating warc id

-

originating url

https://data.commoncrawl.org/crawl-data/CC-MAIN-2025-33/segments/1754151279919.59/warc/CC-MAIN-20250806171101-20250806201101-00801.warc.gz

source type

11 (CommonCrawl)

Server response

server ip

172.64.149.50

Publication date

2025-08-06 17:22:18

Fetch attempts

0

Original html size

92416

Normalized and saved size

89417

Content

title

Publication d’études cliniques - Epcoritamab: Tepkinly

excerpt

content

Wir publizieren Synopsen aus Clinical Study Reports (CSR), um die öffentlichen Informationen zu ergänzen. Dadurch stehen Patienten und Gesundheitsdienstleistern die Ergebnisse unserer klinischen Studien und die zur Zulassung von Tepkinly verwendeten Nachweise zur Verfügung. Finden Sie hier die CSR-Synopsen nach Erhalt der befristeten Zulassung von Tepkinly in der Schweiz.

author

updated

2026-01-01 09:58:02

Text analysis

block type

0

extracted fields

104

extracted bits

title
full content
content was extracted heuristically

detected location

0

detected language

2 (German)

category id

German articles (239)

index version

2025123101

paywall score

0

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

319

text words

49

text unique words

40

text lines

1

text sentences

3

text paragraphs

1

text words per sentence

16

text matched phrases

0

text matched dictionaries

0